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1738 | Chem. Sci., 2016, 7, 1738–1752rs self-assembly and unmasks
innate immune function of a human a-defensin
peptide†
Phoom Chairatana,a Hiutung Chu,‡b Patricia A. Castillo,‡b Bo Shen,c
Charles L. Bevinsb and Elizabeth M. Nolan*a
Human a-defensin 6 (HD6) is a unique peptide of the defensin family that provides innate immunity in the
intestine by self-assembling to form higher-order oligomers that entrap bacteria and prevent host cell
invasion. Here, we report critical steps in the self-assembly pathway of HD6. We demonstrate that HD6
is localized in secretory granules of small intestinal Paneth cells. HD6 is stored in these granules as an
81-residue propeptide (proHD6), and is recovered from ileal lumen as a 32-residue mature peptide. The
propeptide neither forms higher-order oligomers, nor agglutinates bacteria, nor prevents Listeria
monocytogenes invasion into epithelial cells. The Paneth cell granules also contain the protease trypsin,
and trypsin-catalyzed hydrolysis of proHD6 liberates mature HD6, unmasking its latent activities. This
work illustrates a remarkable example of how nature utilizes a propeptide strategy to spatially and
temporally control peptide self-assembly, and thereby initiates innate immune function in the human
intestine.Introduction
The innate immune system mediates homeostasis at mucosal
surfaces, in part by providing protection from microbial inva-
sion. Host-defense peptides are abundant and important
players in the interplay between host and microbe at mucosal
surfaces.1,2 The intestine harbors the largest reservoir of colo-
nizing microbes, termed the microbiota, and this diverse
community is mostly comprised of microorganisms that are
benecial to the host. Nevertheless, some resident members of
this community, as well as many transient microbes, can invade
the epithelium and thus pose a signicant challenge for theInstitute of Technology, Cambridge, MA
+1-617-324-0505; Tel: +1-617-452-2495
y, University of California Davis School of
nd Gastroenterology and Hepatology, The
44195, USA
(ESI) available: Tables of amino acid
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s of characterization of HD6 in ileal
, SDS-PAGE, HPLC traces, antibacterial
talyzed degradation of recombinant
from trypsinized proHD6, TEM of
r and at different time points, SEM of
oHD6, cytotoxicity studies of proHD6
n velocity analysis, and sedimentation
10.1039/c5sc04194eimmune system to effectively protect the host and maintain
intestinal homeostasis. Paneth cells, secretory cells located at
the bases of the crypts of Lieberku¨hn in the small intestine,
contribute to mucosal innate immunity by releasing a cocktail
of host-defense peptides and proteins in response to microbial
stimuli.3–5 In humans, Paneth cells express two a-defensins,
human defensins 5 and 6 (HD5 and HD6).6–9 Defensins are
small (2–5 kDa) cysteine-rich host-defense peptides expressed
by epithelial cells and neutrophils. These peptides typically
exhibit broad-spectrum antimicrobial activity.2,10,11 a-Defensins
exhibit three regiospecic disulde bonds (CysI–CysVI, CysII–
CysIV, CysIII–CysV) in the oxidized form, which stabilize a three-
stranded b-sheet fold and confer protease resistance.12–14 The
oxidized form of HD6, in contrast to HD5 and other character-
ized a-defensins, exhibits negligible in vitro antimicrobial
activity.12,15–18 Based on in vivo model studies and in vitro char-
acterization, HD6 operates by an unprecedented host-defense
mechanism involving its unusual self-assembly properties.15,17
HD6 monomers oligomerize into extended structures termed
“nanonets” and thereby entrap bacteria in the small intestinal
lumen. This capture mechanism prevents bacterial invasion
into host epithelial cells and subsequent dissemination to other
organs.15,17 The HD6 nanonets have been observed in vivo and in
vitro, with the former studies employing HD6 transgenic mice
infected with the enteric pathogen Salmonella enterica serovar
Typhimurium (S. Typhimurium).17
A number of fundamental chemical and biological questions
about HD6 arise from prior studies. First, our understanding of
HD6 is limited because the peptide has not been isolated andThis journal is © The Royal Society of Chemistry 2016
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View Article Onlinecharacterized from human intestine. Current assumptions
about mature HD6 are based on one study in which the peptide
was detected in urine specimens obtained from bladder cancer
patients with surgically created ileal neobladders.19 There are
also uncertainties related to HD6 storage and maturation. In
particular, how do Paneth cells package and deploy a self-
assembling peptide from granules, and how is formation of
nanonets regulated? Analysis of human mRNA indicated that
HD6 is translated as a 100-residue prepropeptide.7 This pre-
propeptide is predicted to contain a 19-residue N-terminal
signal sequence that targets the peptide to the secretory
pathway, and an 81-residue C-terminal region that corresponds
to a putative mature HD6 and an intervening acidic propeptide
domain (Table S1†).7 The HD6 propeptide has not been detected
in a human specimen or characterized to date. Based on prior
studies of a-defensins in humans20–24 and mice,25,26 whether
HD6 is stored as mature peptide or as a propeptide is unclear
because both cases are observed for other human a-defensins,
and mice store a-defensins in their Paneth cells as mature
peptides.
Guided by the biophysical properties of HD6,15 the oxida-
tively folded regioisomer with CysI–CysVI, CysII–CysIV, CysIII–
CysV bonds that is the focus of the current work, we reasoned
that the quaternary structure of a proHD6 and mature HD6
differ. The HD6 crystal structure reveals that mature 32-residue
HD6 monomers are arranged as a chain of tetramers where the
N- and C-termini from four monomers form a hydrophobic
pocket.12,15 On the basis of this structure12 and our studies of
HD6 variants that have defective self-assembly properties,15 we
hypothesized that the N-terminal pro sequence of proHD6
would interrupt the alignment of HD6 monomers and prevent
the formation of higher-order oligomers. We therefore
hypothesized that storage of HD6 as the propeptide in Paneth
cells would prevent HD6 nanonets from forming in the gran-
ules. Moreover, the amino acid sequence of proHD6 (Fig. 1a)
reveals that Arg68 provides a potential trypsin cleavage site,
which is likely relevant because trypsin is expressed and
released by human Paneth cells.24,27 Taken together, these
observations provided us with a testable model whereby Paneth
cells would package HD6 as an inactive propeptide, and that
proteolytic processing by trypsin unleashes mature HD6 in the
intestinal lumen.
Herein, we combine ex vivo analyses of human intestinal
specimens with biophysical characterization and in vitro func-
tional studies of HD6 and its propeptide to interrogate this
model and characterize the HD6 maturation pathway. We
report, for the rst time, the detection and analysis of HD6 from
samples of human intestinal tissue and luminal uid. We
demonstrate that an 81-residue proHD6 isoform exhibiting an
N-terminal extension is found in ileal tissue and 32-residue
mature HD6 is found in luminal uid. We establish that
proHD6 is an inactive isoform. The N-terminal region of
proHD6 suppresses self-assembly and renders proHD6 unable
to agglutinate bacteria and protect human epithelial cells from
bacterial invasion. Moreover, we show that proHD6 is
a substrate for trypsin, and that trypsin-catalyzed hydrolysis of
proHD6 yields the 32-residue mature HD6 found in the lumen.This journal is © The Royal Society of Chemistry 2016In this protease-triggered cascade, trypsin-catalyzed release of
HD6 unmasks latent biological activity by enabling peptide self-
assembly to form the nanonets that can entrap bacterial
invaders.
Results
Identication of HD6 isoforms in human intestinal tissue and
luminal uid
Human Paneth cells express and release two a-defensins, HD5
and HD6.6,7,17,28 Immunogold transmission electron microscopy
(TEM) of human ileal tissue using antibodies that selectively
react with either HD5 or HD6 demonstrated that HD5 and HD6
are co-packaged in Paneth cell secretory granules (Fig. 1b and
S1a†). Because preliminary dot blots revealed that the HD6
antibody (generated to the 32-residue C-terminal peptide17)
reacts with both recombinant proHD6 and mature HD6
(Fig. S1a†), the immunogold labeling did not elucidate which
isoform(s) of HD6 was present in the Paneth cell granules, and
prior work precludes prediction between these storage forms.
For example, mouse Paneth cell a-defensins have an acidic
propeptide (pI z 4.5) and are stored as mature a-defensin
peptides in the secretory granules.25,26 Similarly, human a-
defensins 1–4 (also termed human neutrophil peptides 1–4,
HNP1–4) have acidic propeptides (pI z 5.5) and are stored in
human neutrophil granules as the mature forms (29–30 amino
acids).20–23 In contrast, HD5 has a cationic propeptide (pIz 9.5)
and is stored in Paneth cell granules as a propeptide.24 There-
fore, uncertainty surrounded whether HD6, which has an acidic
propeptide (pIz 4.5), is stored in human Paneth cell granules
as a mature peptide, like mouse Paneth cell a-defensins and
human neutrophil a-defensins, or as a propeptide like HD5
despite its signicantly different pI.
We therefore obtained human ileal tissue from surgical
specimens and prepared protein extracts for analysis by
Western blot, mass spectrometry, and Edman degradation.
Western blot (AU-PAGE, acid urea–polyacrylamide gel electro-
phoresis) analysis of the protein extracts revealed a single band
with HD6 immunoreactivity (Fig. 1c). MALDI-TOF mass spec-
trometry revealed a m/z value of 8962.1, which is in agreement
with the calculated m/z value of 8960.2 for the oxidized form of
proHD6 (Table S2†). Four rounds of Edman degradation affor-
ded an N-terminal sequence of EPLQ that is in agreement with
the N-terminus of the propeptide predicted from mRNA anal-
ysis (Fig. 1c). Data consistent with these ndings were obtained
from specimens of three individuals. These results established
that HD6 is stored in Paneth cells as proHD6, an 81-residue
propeptide, corresponding to residues 20–100 of the deduced
preproHD6 sequence (Table S1, ESI†). We found no evidence for
the presence of mature HD6 in the tissue samples examined in
this study.
Next, to ascertain which isoform(s) of HD6 is present in the
small intestinal lumen, we analyzed intestinal luminal aspirates
obtained by endoscopy. Western blot (AU-PAGE) of the luminal
uid revealed a single band of HD6 immunoreactivity (Fig. 1d).
We fractionated the luminal uid by HPLC and screened the
resulting fractions using HD6 immunoreactivity (dot blot) andChem. Sci., 2016, 7, 1738–1752 | 1739
Fig. 1 Identification and characterization of HD6 in intestinal tissue and fluid. (a) Left: primary amino acid sequences of proHD6 and HD6. The
pro region is in red, the sequence of mature HD6 is in purple, and the disulfide linkages are depicted as black lines. The underlined amino acid
sequences are matched with the results from Edman degradation shown in (c) and (d). Right: the crystal structure of mature HD6 (PDB ID:
1ZMQ).12 The disulfide bonds are shown in yellow. (b) Immunogold labeling transmission electronmicroscopy of human small intestinal tissue. (i)
Left panel: low magnification of Paneth cell granules as a negative control where primary antisera was omitted, scale bar ¼ 2 mm. (ii) Center-left
panel: immunogold double-labeling of Paneth cell granules for HD5 (5 nm gold particles) and HD6 (15 nm gold particles), scale bar¼ 500 nm, (iii)
center-right panel: immunogold labeling of a single Paneth cell granule demonstrating co-packaging of HD5 (5 nm gold particles, open
arrowheads) and HD6 (15 nm gold particles, filled arrowheads), scale bar ¼ 200 nm. (iv) Right panel: immunogold double-labeling of Paneth cell
granules for HD5 (5 nm gold particle, open arrowheads) and trypsin (15 nm gold particles, filled arrowheads), scale bar ¼ 100 nm. (c) and (d)
Analysis of HD6 in human small intestinal tissue (c) and luminal fluid (d) by Western blot, mass spectrometry, and N-terminal Edman degradation.
Tissue extracts of human ileum and ileal fluid aspirates were resolved by AU-PAGE, transferred onto a PVDF membrane, and probed for HD6.
Two separate gels with mobility normalized according to migration of tracking dye to gel bottom are shown and reveal HD6 immunoreactivity in
both samples.
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View Article OnlineMALDI-TOF mass spectrometry. We detected only one HD6
isoform characterized by a m/z value of 3709.9, which corre-
sponds to the oxidized form of the 32-residue mature peptide
(calculated m/z 3708.1 for residues 69–100 of the prepropeptide
deduced from mRNA analysis) (Fig. 1d, S1 and Table S2†). This
assignment was conrmed by seven rounds of Edman degra-
dation, which afforded the N-terminal sequence AFTCHCR
(Fig. 1d). Moreover, this HD6 isoform was the only one detected
by MALDI-TOF mass spectrometry from luminal uid speci-
mens obtained from a total of six individuals.
A comparison of the N-terminal residues of the luminal HD6
peptide with the deduced cDNA sequence7 indicated that
proteolytic processing of the propeptide occurred on the C-1740 | Chem. Sci., 2016, 7, 1738–1752terminal end of Arg68 (Fig. 1a). In agreement with our hypoth-
esis, this cleavage site is consistent with trypsin-catalyzed
hydrolysis of the amide bond linking Arg68 and Ala69. Previous
studies reported that trypsin is expressed by human Paneth
cells,24,27 and demonstrated that trypsin processes proHD5 to
release the 32-residue mature form.24,27 A denitive experiment
to show co-packaging of this protease and either of these a-
defensins in Paneth cell granules has not been reported,
however. We extended our immunogold co-labeling studies of
human ileal tissue to include trypsin, and conrmed that
human enteric a-defensins and trypsin are co-packaged in the
granules (Fig. 1b). In total, our analyses of HD6 in human ileal
tissue and luminal uid support a model whereby the peptide isThis journal is © The Royal Society of Chemistry 2016
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View Article Onlinestored in the secretory granules of Paneth cells as an 81-residue
propeptide. Either during or aer granule release into the
lumen, proHD6 is cleaved by trypsin to generate HD6, the
mature 32-residue peptide found in the intestinal lumen
(Fig. S2†).Trypsin-catalyzed proteolysis of proHD6 provides mature HD6
To enable in vitro studies of proHD6, we obtained recombinant
proHD6 following expression of His6-SUMO-proHD6 in Escher-
ichia coli. This affinity tag allowed the rst recombinant prep-
aration and purication of native 81-residue proHD6. Ulp-1
digestion of His6-SUMO-proHD6 afforded proHD6 as a mixture
of species resulting from peptide oxidation and disulde bond
formation. A sample of the oxidized form, the regioisomer
exhibiting the three native a-defensin disulde linkages (Cys4–
Cys31, Cys6–Cys20, Cys10–Cys30), was obtained following chem-
ical reduction of the peptide to yield the reduced form with six
free thiols, oxidative folding, and purication (Table S2 and
Fig. S3†). We conducted antimicrobial activity assays with
proHD6 (Fig. S4†) and determined that proHD6 does not exhibit
antibacterial activity against Escherichia coli ATCC 25922 or
Listeria monocytogenes ATCC 19115, two strains employed in
this work.
To test our hypothesis that trypsin-catalyzed hydrolysis of
proHD6 affords mature HD6, we conducted in vitro proteolysis
assays (Fig. 2 and S5†). Under the conditions of this experiment
(1 : 100 trypsin : proHD6 (w/w) in 100 mM Tris–HCl, 20 mM
CaCl2, pH 8.0), trypsin accepted proHD6 as a substrate, and
cleavage of the propeptide was observed. Analytical HPLC and
LC/MS of the product mixture revealed HD6 as well as a number
of peptides corresponding to fragments of the propeptideFig. 2 In vitro trypsin-catalyzed cleavage of proHD6. Analytical HPLC
traces of trypsin-treated proHD6 (30 mM  80 mL) at indicated time
points. The trypsin concentration was 0.01 mg mL1 (1 : 100 tryp-
sin : proHD6 (w/w)). Absorbance at 220 nm was monitored with
a reference wavelength of 500 nm. Method: 10–60% B over 30 min at
1 mL min1. The HPLC trace of HD6 is shown in purple as a standard.
Full analysis of the product peaks is given in Fig. S6.†
This journal is © The Royal Society of Chemistry 2016domain (Fig. S6†). Moreover, these assays conrmed that the
mature 32-residue HD6 is resistant to trypsin-catalyzed degra-
dation (Fig. S5†). This observation is consistent with previous
studies of other defensins, which demonstrated that the disul-
de array confers protease resistance.13,14 These data, coupled
with the presence of trypsin and HD6 in Paneth cells, implicate
trypsin as the processing enzyme for HD6 maturation; however,
we cannot exclude the possibility that other proteases
contribute to proHD6 cleavage aer secretion.Trypsin cleavage of proHD6 unmasks latent bacterial
agglutination activity
To probe whether proHD6 can self-assemble, we rst imaged
samples of proHD6 prepared in different buffers by trans-
mission electron microscopy (TEM). The images of proHD6
were indistinguishable from the buffer-only controls, and we
observed no evidence for the formation of higher-order oligo-
mers (Fig. 3 and S7†). This property sharply contrasts with that
of mature HD6, which forms extended brils that are >1 mm in
length under the same experimental conditions (Fig. 3 and S7†).
Moreover, when we added trypsin to proHD6 prior to TEM, we
observed bril-like features comparable to those observed for
the mature HD6 peptide (Fig. 3 and S7†). Time-course experi-
ments revealed that the bril length increased with longer
trypsin treatment (Fig. S8†). Aer a 5 min incubation with
trypsin, relatively short brils were observed, whereas aer 60
min, the brils closely resembled those of mature HD6. This
experiment indicates that proHD6 cannot self-assemble into
higher-order oligomers, but that trypsin-catalyzed hydrolysis of
the propeptide affords this functional activity.
Next, we investigated the bacterial agglutination properties
of proHD6 using scanning electron microscopy (SEM). Previous
investigations demonstrated that mature HD6 agglutinates
Gram-negative15,17 and Gram-positive bacteria.15 Treatment of E.
coli ATCC 25922 or E. coli Nissle with proHD6 (3 mM) yielded no
distinguishable agglutination. The bacteria appeared compa-
rable to the buffer-only control and nanonets were not observed
(Fig. 3, S9 and S10†). Treatment of proHD6 with trypsin prior to
incubation with bacteria resulted in entangled and agglutinated
E. coli in the SEM images, indistinguishable from the aggluti-
nation observed for E. coli treated with mature HD6 (Fig. 3, S9
and S10†). We found that treatment of S. Typhimurium,
another Gram-negative bacterium, with mature HD6 resulted in
entangled and agglutinated bacteria (Fig. S11†), consistent with
previous studies.17 As observed for E. coli, proHD6 did not
agglutinate S. Typhimurium unless it was treated with trypsin
prior to incubation with the bacteria (Fig. S11†). Finally, we
observed the same trypsin-dependent activity of proHD6 with
the Gram-positive bacterium L. monocytogenes (Fig. 3 and S12†).
Thus, the SEM investigations provide evidence that mature HD6
readily agglutinates both Gram-negative and Gram-positive
bacteria, whereas proHD6 lacks this activity until it is processed
by a protease.
We previously reported a simple cuvette-based in vitro
agglutination assay that enables time-dependent monitoring of
agglutination of viable bacteria by HD6.15 We employed thisChem. Sci., 2016, 7, 1738–1752 | 1741
Fig. 3 TEM analysis of HD6 self-assembly and SEM analysis of bacterial agglutination. Top row: transmission electron micrographs of 10 mM
sodium phosphate pH 7.4 (control), 0.4 mM trypsin (control), 20 mM proHD6 in the absence and presence of 0.4 mM trypsin, and 20 mM HD6. All
the samples were incubated at room temperature for 1 h. Scale bar ¼ 100 nm. TEM images obtained using 10 mM Tris-maleate pH 6.4 are
presented in Fig. S7.†Middle row: scanning electronmicrographs of E. coli ATCC 25922 treatedwith 50mMTris-maleate pH 6.4 (control), 0.4 mM
APMSF-inactivated trypsin (control), 3 mM proHD6, 3 mM trypsin-cleaved proHD6, or 3 mM HD6. Trypsin-cleaved proHD6 was prepared prior to
incubation with the bacteria and the residual enzymatic activity was inhibited by APMSF (Experimental section). Following a 30 min incubation,
the bacterial suspensions were centrifuged, fixed, and analyzed by SEM. Scale bar ¼ 20 mm. Bottom row: SEM of L. monocytogenes ATCC19115
treated under the same conditions as in the middle row. Scale bar ¼ 20 mm. Additional SEM images are shown in Fig. S9–S12.†
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
D
ec
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
4/
09
/2
01
7 
10
:3
3:
11
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineassay to further characterize the trypsin-dependent activity of
proHD6 on cultured bacterial cells (Fig. 4a and b). When
proHD6 was added to a suspension of either E. coli or L. mon-
ocytogenes (108 CFU mL1), the cultures remained homoge-
neous for the 6 h duration of the assay, even at the highest
concentration of proHD6 evaluated (20 mM). In contrast,
bacterial agglutination and sedimentation occurred when
a combination of proHD6 and trypsin was added to the bacterial
cultures (Fig. 4a and b), with kinetics comparable to those ob-
tained for cultures treated with mature HD6. In these assays, we
dened the “supernatant” as the culture solution in the top
portion of the cuvette and the “re-suspension” as the mixture
that results from agitating the entire culture aer the 6 h
incubation period.15 We observed anz1.5-fold log reduction in
CFU mL1 for the “supernatant” from cultures treated with
combination of trypsin and proHD6 relative to the no-peptide
control (Fig. 4c). Following “re-suspension”, the total CFUmL1
in the cuvette was indistinguishable from that of either the
untreated control culture or the bacterial culture treated with
proHD6. These results indicated that the reduction of CFU
mL1 in the “supernatant” for the cultures treated with proHD6
and trypsin was a result of bacterial agglutination and sedi-
mentation rather than bacterial cell death.Proteolysis of proHD6 protects human epithelial cells from
Listeria invasion
Consistent with our recent study,15 mature HD6 ($2.5 mM)
blocks L. monocytogenes invasion into human intestinal
epithelial cells (Fig. 5). In contrast to these ndings with mature1742 | Chem. Sci., 2016, 7, 1738–1752HD6, proHD6 (#10 mM) did not impair the ability of L. mono-
cytogenes to invade intestinal epithelial cells (Fig. 5). However,
when proHD6 ($2.5 mM) was treated with trypsin, the
percentage of L. monocytogenes invasion decreased fromz10%
to <2%, similar to the decrease observed for equivalent
concentrations of mature HD6 (Fig. 5). Taken together with the
agglutination studies, these results indicate that trypsin-cata-
lyzed hydrolysis of proHD6 triggers L. monocytogenes entrap-
ment, which prevents this pathogen from invading mammalian
cells. In control experiments, nuclear morphology assays indi-
cated that neither proHD6 nor HD6 exert cytotoxic effects on the
epithelial cells over the course of these assays (Fig. S13†).Structural determinants of proHD6 impair self-assembly
The in vitro studies of proHD6 function obtained thus far
suggest that this isoform is inactive as a result of suppressed
self-assembly, leaving unanswered how the propeptide segment
interferes with this process. Circular dichroism (CD) spectros-
copy provides a ngerprint for mature HD6 oligomers because
the CD signature of the HD6 self-assembly is characterized by
a negative peak at 192 nm and positive peaks at 205 and 230 nm
at pH 7.4 (Fig. 6a).15 Under the same conditions, the CD spec-
trum of proHD6 markedly differs with a negative peak at 197
nm, resembling the CD signatures of random-coils. Together
with the initial TEM studies, these data provide biophysical
evidence that the pro region interferes with the self-assembly
process characteristic of mature HD6.
We employed analytical ultracentrifugation (AUC) to further
evaluate the quaternary structure of proHD6. We determinedThis journal is © The Royal Society of Chemistry 2016
Fig. 4 Bacterial agglutination assays for native and cleaved proHD6. (a) Agglutination of E. coli ATCC 25922 and L. monocytogenes ATCC 19115
in 50% MHB treated with proHD6 in the absence and presence of 0.4 mM trypsin or HD6 (control). (b) Representative images of cuvettes
containing E. coli ATCC 25922 or L. monocytogenes ATCC 19115 after incubation with 20 mM peptides for 2 h at room temperature. (c) Plots of
colony forming units (CFUmL1) of E. coli ATCC 25922 and L. monocytogenes ATCC 19115 after treatment with 20 mM peptides for 6 h (mean
SDM, n ¼ 3). Supernatant is defined as the clarified medium solution in the top portion of the culture and resuspension is defined as the mixture
after thoroughly agitating the heterogeneous solution.
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View Article Onlinethe sedimentation coefficients of proHD6 prepared in different
buffers (Table S4†). When we prepared proHD6 (#140 mM) at
pH 7.4 in 10 mM sodium phosphate buffer, a single peak at
z 1.8 S was obtained over the range s20,w ¼ 0.5–3.5 S in the
Gaussian ts of the dc/dt distributions obtained using
DCDT+29 (Fig. 6b and S14a†). The Gaussian ts support the
predominance of a single species of proHD6 over a concentra-
tion range of 30–140 mM at pH 7.4. Substitution of sodium
phosphate with HEPES or Tris–HCl buffer at pH 7.4 had
a negligible effect on the s value for proHD6 (Fig. S14b and
Table S4†). In contrast to proHD6, attempts to evaluate mature
HD6 by AUC were not successful because HD6 sedimented too
rapidly even at the lowest speed that AUC can provide (3000
rpm) and coated the AUC cell.15 Nevertheless, AUC studies of
mature HD6 variants that could not form brils observable by
TEM yielded s values that conrmed their limited ability to
oligomerize.15
Because this work includes the rst isolation and biophysical
evaluation of proHD6, there is no proHD6 crystal or solutionThis journal is © The Royal Society of Chemistry 2016structure available that can be used to calculate sedimentation
coefficients. We therefore estimated the sedimentation coeffi-
cients of proHD6 (see Experimental section) under the
assumption that it behaves as a smooth, compact, spherical
peptide in water at 20 C, which afforded values of 1.7 S
(monomer) and 2.8 S (dimer). A caveat to this analysis is that the
49-residue N-terminal pro domain of proHD6 is likely dynamic,
and it is unlikely that proHD6 behaves as a spherical peptide in
aqueous solution.30 Nevertheless, comparison of the experi-
mental and estimated s values suggests that proHD6 exists in
monomer–dimer equilibrium with rapid association under
these experimental conditions. We also conducted sedimenta-
tion equilibrium (SE) experiments to determine the molecular
weight of proHD6 in solution (10 mM sodium phosphate, pH
7.4). Using SEDPHAT31 for a global analysis of the data, we ob-
tained a molecular weight of 15 549 Da with a standard devia-
tion of 230 Da. At the 95% condence level, the interval
ranged from 15 059 Da to 15 946 Da using a Monte Carlo
analysis of the t (Fig. S15 and Table S5†). The molecularChem. Sci., 2016, 7, 1738–1752 | 1743
Fig. 5 Listeria invasion assays for native and cleaved proHD6. Invasion
of human T84 colon epithelial cells by L. monocytogenes ATCC 19115
pre-treated with proHD6 in the absence and presence of 0.4 mM
trypsin or HD6 (control). The bacteria (2  106 CFU mL1) were
incubated with the indicated peptides for 30 min prior to the infection
of the T84 cells (mean  SDM, n ¼ 3).
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View Article Onlineweights of a proHD6 monomer and dimer are 8961 and 17 922
Da, respectively. Thus, the experimental molecular weight of
15 549 Da indicates that the predominant proHD6 species under
these conditions is a dimer and that monomer–dimer equilib-
rium occurs. Thus, these data are consistent with a model where
proHD6 monomers can reversibly associate to form dimers,
whereasmature HD6 readily self-assembles to form higher-order
complexes. Proteolysis therefore serves as a biochemical switch
to induce these pivotal biophysical characteristics.Discussion
In this work, we combined evaluation of HD6 localization and
characterization in human intestinal specimens with in vitro
functional studies and biophysical characterization to provideFig. 6 Biophysical characterization of proHD6. (a) CD spectra of 20 mM
buffer, pH 7.4. (b) Analytical ultracentrifugation of 140 mM proHD6 in 10 m
obtained from sedimentation velocity experiments (absorbance at 280 n
summary of the fits is provided in Table S4.† (c) Sedimentation equilibrium
Best fits (black lines) of raw UV absorbance at 280 nm at rotor speeds
calculated molecular weights are summarized in Table S5.†
1744 | Chem. Sci., 2016, 7, 1738–1752a model for the storage and maturation of this Paneth cell
defensin. HD6 is an unusual defensin that lacks the typical
broad-spectrum in vitro bactericidal activity of other defensins.
It contributes to mucosal immunity by self-assembling into
oligomeric structures, called nanonets, that entrap bacterial
pathogens and block their invasion both in vitro and in vivo.15,17
This study illuminates a number of important facets pertaining
to how HD6 is stored in the granules of Paneth cells and the
mechanism of HD6 self-assembly in the intestinal lumen. First,
our characterization of human ileal tissue demonstrates the co-
packaging of HD5, HD6, and trypsin within the secretory
granules of Paneth cells. Our analyses of ileal tissue protein
extracts and luminal uid enabled us to detect two distinct
isoforms of HD6, the 81-residue propeptide that was only
detected in the tissue samples and the 32-residue mature form
that was only found in the luminal uid. The N-terminal
sequence of the mature HD6 peptide is consistent with cleavage
of proHD6 by trypsin. On the basis of these observations and
the primary sequence of proHD6, we proposed and tested
a model whereby proHD6 is proteolytically cleaved to liberate
mature HD6, which triggers its self-assembly in the gut. Our in
vitro investigations show that trypsin-catalyzed hydrolysis of
proHD6 generates the 32-residue defensin peptide and that this
mature defensin is stable to further proteolysis. Moreover, our
bacterial agglutination assays and biophysical characterization
of proHD6 further inform this model by demonstrating that
proHD6 cannot self-assemble into high-order oligomers or
cause bacterial entrapment. Our work thus establishes that
Paneth cells package HD6 in an inactive form and that prote-
olysis triggers its innate immune activity in the intestine. This
process provides spatial and temporal control of peptide self-
assembly and thereby unveils the protective properties of this
molecule at the intestinal mucosa.
The observed co-packing of defensin propeptides and
trypsin in human Paneth cell granules indicates that trypsin isproHD6 (red) and 20 mM HD6 (purple) in 10 mM sodium phosphate
M sodium phosphate buffer, pH 7.4. The blue dots are the dc/dt data
m). The red line is the single Gaussian fit obtained using DCDT+. The
profiles of 120 mM proHD6 in 10mM sodium phosphate buffer, pH 7.4.
of 30 000 (red), 36 000 (blue), and 42 000 (green) rpm. The fits and
This journal is © The Royal Society of Chemistry 2016
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View Article Onlineinactive at this biological site. The mechanism underlying this
lack of trypsin activity is currently unknown and a topic for
future investigation. Spatial and temporal control of protease
activity can be achieved by alterations in local pH or calcium ion
concentration, the presence of protease inhibitors, and storage
as a zymogen. Along these lines, human Paneth cells produce
a1-antitrypsin,24,32 and this protein may inhibit trypsin pack-
aged in the granules. We also reason that trypsin might be
stored in the granules as a zymogen, trypsinogen, and activated
by enterokinase or an enterokinase-like enzyme following
release into the lumen. This model is based on the known
processing of trypsinogen produced by pancreatic exocrine cells
in the human intestine.
Whereas most a-defensins crystallize as dimers, the crystal
structure of 32-residue HD6 revealed that a hydrophobic pocket
occurs between four HD6 monomers.12,15 In each hydrophobic
pocket, two monomers each contribute Phe2, Phe29 and Leu32,
and the two other monomers each contribute Val22, Met23 and
Ile25. The N- and C-termini of 32-residue HD6 are within close
proximity, and residues at both the N- and C-terminal ends are
constituents of this hydrophobic pocket. On the basis of the
analytical ultracentrifugation studies presented here, the N-
terminal pro-region prevents formation of this hydrophobic
pocket and thereby self-assembly to higher-order oligomers.
Elucidating whether the pro-region merely provides a steric
block to self-assembly or whether specic amino acid side-
chains in the pro-region are required for preventing HD6 olig-
omerization needs further biophysical investigations.
Our understanding of the roles of defensin propeptides and
defensin maturation is limited, and the insights from the
current work may also be considered in the context of reported
observations about the proteolytic processing and maturation
of other a-defensins.24–26,33,34 Although conversion from a pro-
peptide to a mature form is common amongst a-defensins, the
pro-regions of a-defensins exhibit variable primary sequences,
and the maturation pathways and proteases involved in pro-
peptide processing are oentimes unknown. On the basis of
characterized systems, some defensins are packaged as pro-
peptides whereas others are stored in the mature forms, making
it necessary to examine speciation on a case-by-case basis. A
comparison of the human a-defensins illustrates this point.
Previous studies24,35 and the current work demonstrate that the
enteric a-defensins HD5 and HD6 are stored in Paneth cell
granules as propeptides. In contrast, the human neutrophil
peptides (HNP1–4) are stored in neutrophil granules as the
mature, z30-residue peptides.20–22 The HD5 propeptide is
highly cationic (pI z 9.5) whereas the HD6 and HNP propep-
tides are anionic (pIz 4.5 for HD6; pIz 5.5 for HNPs). These
comparisons indicate that the amino acid composition of the
propeptide region does not provide a reliable predictor of
whether a given peptide will be processed before or aer
packaging into granules, at least based on our current under-
standing. Moreover, prior studies of human ileal uid detected
several different isoforms of HD5 where the N-terminal pro-
region was truncated at different positions as a result of
proteolytic processing at different sites, and all of these species
displayed antibacterial activity.24 This observation contrastsThis journal is © The Royal Society of Chemistry 2016with the current results for HD6, where homogeneous immu-
noreactivity was observed by AU-PAGE and only the 32-residue
mature HD6 was detected in ileal uid. Lastly, mice also harbor
enteric a-defensins that are packaged in Paneth cell granules.
Like human a-defensins, the murine a-defensins are translated
as propeptides. In contrast to HD5 and HD6, the murine a-
defensins are packaged in Paneth cell granules as the mature
peptide and matrix metalloproteinase 7 has been implicated as
the processing enzyme.25,26 Taken together, nature has deployed
a variety of strategies for defensin maturation even within
a particular class for reasons that are as-yet undetermined and
warrant exploration in future work.
At mucosal surfaces throughout the body, numerous host
peptides and proteins boost barrier effectiveness of the
epithelia. By inhibiting bacterial invasion, HD6 contributes to
barrier function of the innate immune system at the intestinal
mucosa, augmenting the contributions of other key biomole-
cules at this surface such as mucus36 and lectins.37 The adaptive
immune system also contributes to barrier function by using
immunoglobulin A, which is abundant in the intestine and
other mucosal surfaces, to block bacterial invasion.38–40 Thus,
the combined invasion-inhibiting activities of the innate and
adaptive immune systems fortify the integrity of the intestinal
barrier to mediate intestinal homeostasis. Further investiga-
tions are required to elucidate additional mechanistic details
pertaining to how HD6 performs its host-defense function. In
particular, how HD6 function integrates with other host-
defense molecules deployed at the intestinal mucosa requires
investigation, and whether HD6 affects the population
dynamics of human gut commensal organisms under normal or
pathological conditions is another important avenue for future
work.
In closing, propeptides are employed as inactive precursors
to suppress the biological functions of various peptides and
proteins, and proteases are enlisted to unleash the activity of
the mature isoforms on demand.24,41,42 The N-terminal exten-
sion from mature HD6 is a fascinating variation on this general
theme, which allows for suppression of peptide self-assembly
and storage of HD6 in Paneth cells as an inactive form. The
protease-triggered self-assembly of HD6 is reminiscent of
neuropeptides that form higher-order oligomers following
a protease cleavage event, including the prion protein and Ab(1–
42).43–45 In such cases, oligomer formation is associated with
disease.46,47 Protease-triggered self-assembly of HD6, in
contrast, affords a benecial outcome to intestinal homeostasis
by spatial and temporal control of its host-defense function
entrapping bacterial invaders.
Experimental section
Materials and general methods
All solvents, reagents, and chemicals were purchased from
commercial suppliers and used as received unless noted
otherwise. The mature 32-residue forms of HD5 and HD6 were
recombinantly overexpressed and puried as previously
described.14,15 These procedures involve oxidative folding,
which allows for isolation of the native CysI–CysVI, CysII–CysIV,Chem. Sci., 2016, 7, 1738–1752 | 1745
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View Article OnlineCysIII–CysV regioisomers following purication. All functional
and biophysical studies were performed with oxidatively folded
peptides. Milli-Q water (18.2 mU cm) was passed through a 0.22
mm lter before it was used to prepare all buffers, aqueous
solutions, and peptide/oligonucleotide stock solutions. Oligo-
nucleotide primers were synthesized by Integrated DNA Tech-
nologies (Coralville, IA) and used as received (standard
desalting protocol). A Biorad MyCycler thermocycler was
employed for all polymerase chain reactions (PCR). Chemically-
competent E. coli TOP10 and BL21(DE3) cells were prepared in-
house via standard protocols. PfuTurbo DNA polymerase was
purchased from Agilent Technologies. T4 DNA ligase and all
restriction enzymes were purchased from New England Biolabs.
DNA sequencing was performed by staff in the Biopolymers
Facility at the Massachusetts Institute of Technology.Instrumentation
Unless noted otherwise, analytical and semi-preparative high-
performance liquid chromatography (HPLC) were performed on
an Agilent 1200 instrument equipped with a thermostatted
autosampler set at 4 C and thermostatted column compart-
ment generally set at 20 C, and a multi-wavelength detector set
at 220 and 280 nm (500 nm reference wavelength with 100 nm
bandwidth). Preparative HPLC was performed using an Agilent
PrepStar 218 instrument outtted with an Agilent ProStar 325
UV-visible dual-wavelength detector set at 220 and 280 nm. A
Clipeus C18 column (5 mm particle size, 4.6  250 mm, Higgins
Analytical, Inc.) set at a ow rate of 1 mL min1 was employed
for all analytical HPLC experiments. A ZORBAX C18 column (5
mm particle size, 9.4  250 mm, Agilent Technologies, Inc.) set
at a ow rate of 5 mL min1 was employed for all semi-
preparative-scale HPLC purication. A Luna 100 A˚ C18 LC
column (10 mm particle size, 21.2  250 mm, Phenomenex) set
at a ow rate of 10 mL min1 was utilized for all preparative-
scale HPLC purication. HPLC-grade acetonitrile (MeCN) and
HPLC-grade triuoroacetic acid (TFA) were routinely purchased
from EMD and Alfa Aesar, respectively. For all HPLC runs,
solvent A was 0.1% TFA/H2O and solvent B was 0.1% TFA/
MeCN.
High-resolution mass spectrometry was performed by using
an Agilent LC-MS system comprised of an Agilent 1260 series LC
system outtted with an Agilent 6230 TOF system housing an
Agilent Jetstream ESI source. For all LC-MS analyses, solvent A
was 0.1% formic acid/H2O (LC-MS grade, Sigma-Aldrich) and
solvent B was 0.1% formic acid/MeCN (LC-MS grade, Sigma-
Aldrich). A Poroshell 120 EC-C18 column (2.7 mm particle size,
2.1  100 mm, Agilent Technologies, Inc.) set at a ow rate of
0.4 mL min1 was employed for all LC-MS analyses of HD6. The
samples were analyzed by using a gradient of 5–95% B over 5
min. A Poroshell 300SB C18 column (5 mmparticle size, 2.1 75
mm, Agilent Technologies, Inc.) set at a ow rate of 0.2 mL
min1 was employed for all LC-MS analyses of proHD6. The
samples were analyzed by using a gradient of 5–65% B over 30
min. The MS proles were analyzed and deconvoluted by using
Agilent Technologies Quantitative Analysis 2009 soware
version B.03.02.1746 | Chem. Sci., 2016, 7, 1738–1752A Beckman Coulter DU 800 UV-visible spectrophotometer
was employed for all routine optical absorption measurements
and aggregation assays. Extinction coefficients (280 nm) were
calculated by using ExPASy ProtParam. The calculated extinc-
tion coefficients of native HD6, proHD6, and His6-SUMO-
proHD6 are 4845, 6335, and 7825 M1 cm1, respectively.
Peptide stock solutions were routinely prepared in Milli-Q water
and concentrations were quantied by using the calculated
extinction coefficients. Solution and buffer pH values were
veried by using a Mettler Toledo S20 SevenEasy pH meter or
a HANNA Instruments HI 9124 pH meter equipped with
a microelectrode. An Aviv Model 202 circular dichroism spec-
trometer operated at room temperature was utilized to collect
CD spectra.
Human specimen samples and ethics approval
The protocols for obtaining tissue specimens and luminal
aspirates were reviewed and approved by the Institutional
Review Board at the Cleveland Clinic Foundation (#06-673) and
informed consent was obtained from all patients. All specimens
were coded so that patient identiers were removed and then
handled as previously described.17,24,48 Nondiseased specimens
of human distal small intestinal tissue were obtained from
redundant surgically-resected tissue as described.24 Small
intestinal lumen uid aspirates were obtained from individuals
undergoing colonoscopy for either routine colon polyp
screening or for assessment of inammatory bowel disease.
Approximately 5–15mL of ileal uid was aspirated, immediately
placed on dry ice, frozen, and stored at 80 C prior to use.
Immunogold labeling and transmission electron microscopy
Human ileal tissue specimens were xed in 4% para-
formaldehyde (EM Science, Hateld, PA) overnight at room
temperature. The tissue was then dehydrated in graded ethanol
and thin-sectioned. Grids were incubated with rabbit polyclonal
HD6 antiserum (1 : 1000),17 mouse monoclonal anti-HD5 IgG
(HyCult, Plymouth Meeting, PA), or rabbit polyclonal trypsin
antiserum (Abcam, Cambridge, MA) for 1 h at room tempera-
ture in a humidied chamber, washed with PBS, and incubated
with 1 : 50 dilution of 5 or 15 nm gold-labeled goat-anti-rabbit
or goat-anti-mouse antibody (EM Science, Hateld, PA) for 30
min. Grids were washed with double-distilled water and visu-
alized on a Philips CM120 Biotwin Lens (F.E.I. Company,
Hillsboro, OR) with Gatan BioScan, model 792 (Pleasanton, CA).
HD6 peptide isolation from intestinal tissue
Protein extraction and fractionation from small intestinal tissue
followed a published protocol,24 with some modications.
Briey, approximately 1 g of human ileal tissue was homoge-
nized with a Brinkmann Polytron homogenizer in ice-cold 20%
acetic acid (1 : 10 w/v) that contained 1 : 100 v/v Protease
Inhibitor Cocktail III. The extract was stirred overnight at 4 C,
and then claried by ultracentrifugation (110 000g  30 min,
4 C). Ammonium sulfate was added (nal concentration of
25% w/v), and the mixture was stirred at room temperature for 1
h, and then claried by ultracentrifugation (110 000g  30 min,This journal is © The Royal Society of Chemistry 2016
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
D
ec
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
4/
09
/2
01
7 
10
:3
3:
11
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online4 C). The supernatant was then dialyzed against 5% v/v acetic
acid overnight at 4 C using Spectro/Por dialysis membrane
(1 kD MWCO, Spectrum Laboratories, Rancho Dominguez, CA).
The resulting solution was passed through a strong cation
exchange cartridge (Bio-Scale Mini Macro-Prep High Q, BioRad,
Hercules, CA), washed with 5% v/v acetic acid, and then eluted
with 1 M NaCl. The eluate was further puried by RP-HPLC
using a Waters 650E HPLC instrument with a variable wave-
length detector (monitored at 214 nm and 280 nm) and a C18
column (Vydec) with a gradient of 5–80% acetonitrile gradient
in 0.1% TFA. Fractions were collected at a ow rate of 1 mL
min1 and analyzed as described for the lumen aspirate
specimens.
HD6 peptide isolation from intestinal lumen uid
The frozen ileal uid aspirate was thawed on ice, and a protease
inhibitor cocktail was added at a ratio of 1 : 100 v/v (Cocktail III,
Calbiochem, La Jolla, CA). The resulting sample was immedi-
ately acidied with acetic acid (20% v/v nal). Clumps and
particulates were dispersed with a Brinkmann Polytron
homogenizer. The sample was claried by centrifugation at
29 000g (2  30 min, 4 C). The supernatant was diluted with
water (1 : 1 v/v), ash frozen, and then lyophilized to dryness.
The lyophilized product was dissolved in 1.5 mL of 5% v/v acetic
acid, and ltered through a Millex 0.22 mm polyether sulfone
lter (EMD-Millipore) to remove residual particulates. A portion
of the sample was then fractionated by reverse phase HPLC (RP-
HPLC) using a Waters 650E instrument outtted with a C18
column (10 mm particle size, 4.6  250 mm, Vydac/Grace,
ColumbiaMD) using a gradient of 5–62%B over 60min at a ow
rate of 1 mL min1. Fractions were collected at 1 min intervals
and absorbance at 220 and 280 nm was monitored. Aliquots of
each fraction were analyzed by MALDI-TOF mass spectrometry
(2 mL aliquot) and for immunoreactivity (20 mL aliquot). Frac-
tions positive for HD6 were then analyzed by Edman degrada-
tion as described below.
MALDI mass spectrometry
A 4700 MALDI TOF/TOF (Applied Biosystems, Foster City, CA)
equipped with a pulsed Nd:YAG laser (337 nm) and a delayed
extraction ion source was employed to screen the HPLC frac-
tions for HD6 isoforms. An aliquot of each fraction (2 mL) was
mixed with an equal volume of a saturated matrix solution (a-
cyano-4-hydroxycinnamic acid in 0.1% TFA/50% MeCN). A 1 mL
aliquot of this mixture was applied to the target plate. The mass
spectra were acquired in linear mode and typicallyz1000 laser
shots were used per sample.
Dot blot immunoreactivity
A dot blot method was used to screen HPLC sample fractions for
HD6 immunoreactivity. A 20 mL aliquot of each fraction was
spotted directly onto an Immobilon PSQ PVDF membrane
(Millipore, Billerica, MA). The protein on the membrane was
then xed with 0.01% w/v glutaraldehyde (Sigma, St. Louis, MO)
for 2.5 min, washed in Tris-buffered saline for 1 min, and the
membrane surface was blocked with 5%w/v non-fat dry milk forThis journal is © The Royal Society of Chemistry 20161 h. The membrane blots were probed with HD6 rabbit poly-
clonal antibody17 (1 : 7000) using a horseradish peroxidase
(HRP)-conjugated goat-anti-rabbit secondary antibody (KPL,
Gaithersburg Maryland). Signal was detected using Immobilon
Western Chemiluminescent HRP substrate (Millipore, Billerica,
MA). The chemiluminescent signal was detected with a Bio-
spectrum AC Imaging System (UVP, Upland, CA).
Edman degradation
Sample fractions with the positive HD6 immunoreactivity and
mass consistent with (pro)HD6 were analyzed by Edman
degradation to determine N-terminal amino acid sequence. The
analysis was performed with a Procise 494 microsequencer
(Applied Biosystems) by staff at the UC Davis Molecular Struc-
ture Facility.
Western blot analysis
Acid urea–polyacrylamide gel electrophoresis (AU-PAGE)
Western blot analysis was performed on small intestinal tissue
and luminal uid as previously described.19,24 Briey, small
intestinal ileal specimens (tissue and luminal aspirate uid)
were homogenized with a Brinkmann Polytron homogenizer in
ice-cold 20% acetic acid (1 : 10 w/v) that contained 1 : 100 v/v
Protease Inhibitor Cocktail III. The resulting suspension was
stirred overnight at 4 C and claried the following day by
ultracentrifugation (110 000g  30 min, 4 C). Aliquots of these
specimens were diluted with 0.5 volume of loading buffer (9 M
urea, 5% v/v acetic acid, 0.1 mgmL1 methyl green (Sigma)) and
then resolved on polyacrylamide gels (12.5% acrylamide/2% bis-
acrylamide (Roche, Indianapolis, IN), 8 M deionized urea
(Sigma), and 5% v/v acetic acid). Samples were run toward the
cathode (reverse typical polarity) at 130 volts in 5% v/v acetic
acid running buffer until the methyl green indicator dye
reached the bottom of the gel (typically z1.5 h). Proteins were
then transferred from the gels to Immobilon PSQ PVDF
membranes in 5% v/v acetic acid using a semi-dry transfer
apparatus (Fisher Scientic, Pittsburgh, PA) at 1.5 mA cm2
toward the cathode for 20 min. Each membrane was then xed,
washed, blocked, and probed as described for the dot blot
analysis.
Subcloning, overexpression, and purication of His6-SUMO-
proHD6
The pET SUMO-proHD6 plasmid was prepared by using the
Champion pET SUMO protein expression system (Invitrogen).
The proHD6 nucleotide sequence (246 bp) was PCR amplied
using pET28b-proHD6 (ref. 15) as a template and the forward
and reverse primers 50-GAGCCGCTGCAAGCAGAG-30 and 50-
TTACAGACAACAAAAGCGATG-30, respectively (stop codon,
italic). The PCR products were analyzed by 1% (w/v) agarose gel
and puried by using a QIAquick PCR purication kit (Qiagen).
The PCR-amplied proHD6 gene was subsequently ligated into
pET SUMO using T4 DNA ligase (9 ng of PCR product, 50 ng of
linear pET SUMO, 1 mL of T4 DNA ligase; 16 h, 16 C). A 1 mL
aliquot of each ligation reaction was transformed into chemi-
cally-competent E. coli Mach1™-T1R cells (Invitrogen). TheChem. Sci., 2016, 7, 1738–1752 | 1747
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View Article Onlineplasmids were isolated by using QIAprep spin miniprep kit
(Qiagen) and the plasmid identities were veried by DNA
sequencing.
The overexpression and purication of His6-SUMO-proHD6
were modied from the procedure for obtaining His6-proHD6.15
pET SUMO-proHD6 was transformed into chemically-competent
E. coli BL21(DE3) cells. Overnight cultures were prepared by
inoculating LB medium containing kanamycin (50 mg mL1)
with single colonies. These cultures were grown to saturation
(37 C, 150 rpm, 16–18 h) and used to prepare freezer stocks.
The freezer stocks, containing a 1 : 1 ratio of the overnight
culture and sterile-ltered 50% glycerol in Milli-Q water, were
stored at 80 C. For a given His6-SUMO-proHD6 over-
expression, 50 mL of LB medium containing 50 mg mL1
kanamycin in a 250 mL baffled ask was inoculated from the
freezer stock and grown to saturation (37 C, 150 rpm, 16–18 h).
The resulting culture was diluted 1 : 100 into 2 L of fresh LB
medium containing 50 mg mL1 of kanamycin in a 4 L baffled
ask and incubated at 37 C, 150 rpm until OD600 ofz0.6 was
achieved. Subsequently, a 400 mL aliquot of 0.5 M isopropyl b-D-
1-thiogalactopyranoside (IPTG) was added to the 2 L culture and
the culture was incubated for an additional 4–5 h until OD600
reached 1.2–1.5. The cells were centrifuged (3000 rpm  15
min, 4 C) and the cell pellets were collected. Overexpression of
His6-SUMO-proHD6 was usually performed on a 12 L scale and
the cell pellets from 6 L of culture were combined in pre-
weighed 50 mL polypropylene centrifuge tubes (z2 g L1 wet
cell weight), ash frozen in liquid N2, and stored at 80 C for
a period of 1–2 months.
For purication of His6-SUMO-proHD6, each 6 L cell pellet
was thawed on ice and resuspended in 40mL of cold lysis buffer
(6 M GuHCl, 100 mM Tris–HCl, pH 8.0). A 1 mL aliquot of
phenylmethyl sulfonyl uoride (PMSF, 100 mM in EtOH) was
added to the resuspension and the cells were transferred to
a pre-chilled stainless steel beaker and lysed on ice by two
rounds of sonication (10% amplitude with pulse on for 1 s and
pulse off for 4 s for 1 min, on ice, Branson sonicator). A second 1
mL aliquot of PMSF (100 mM) was added to the cell lysate fol-
lowed by centrifugation (13 000 rpm  30 min, 4 C). The
resulting supernatant was incubated with pre-washed Ni-NTA
resin (Qiagen, from 9mL of Ni-NTA slurry for a cell pellet from 6
L of culture that was pre-washed 3  30 mL with Milli-Q water)
with gentle shaking for 1.5 h at 4 C. The resulting mixture was
then loaded onto a fritted glass column and the resin was
washed with 40 mL of cold wash buffer (20 mM Tris–HCl, 300
mM NaCl, 6 M GuHCl, pH 8.0). The His6-SUMO-proHD6 fusion
protein was eluted with 30 mL of cold elution buffer (10 mM
Tris–HCl, 300 mM NaH2PO4, 200 mM NaCl, 1 M imidazole, 6 M
GuHCl, pH 6.5). The eluent was diluted with 30 mL of Milli-Q
water, transferred into a dialysis bag (3500 MWCO), and dia-
lyzed (2  12 h) against refolding buffer (20 mM Tris–HCl, 150
mM NaCl, 10% v/v glycerol, 1% w/v CHAPS, pH 8.0). The solu-
tion of His6-SUMO-proHD6 was concentrated to 2 mg mL
1,
transferred to 50 mL polypropylene centrifuge tubes, ash
frozen in liquid N2 and stored at 80 C. The average yield was
20 mg L1 culture. The purity of His6-SUMO-proHD6 was1748 | Chem. Sci., 2016, 7, 1738–1752routinely evaluated by SDS-PAGE (15% Tris–HCl gel). A repre-
sentative gel is shown in Fig. S3a.†Preparation and purication of native proHD6red
To a solution of His6-SUMO-proHD6, tris-(2-carboxylethyl)
phosphine (TCEP, 100 mM stock solution in Milli-Q water) was
added to achieve a nal concentration of 2 mM and the solution
pH was adjusted to pH 8.0 by drop-wise addition of 4 M NaOH.
An 1 mg mL1 stock solution of Ulp1 in 20 mM Tris–HCl,
150 mM NaCl, pH 8.0 was added to the solution containing
His6-SUMO-proHD6 to afford a His6-SUMO-proHD6 : Ulp1 ratio
of 100 : 1 (w/w). The reaction was incubated at room tempera-
ture for 2 h and quenched by addition of 6% aqueous TFA (10%
v/v). The quenched reaction was immediately vortexed and
incubated on ice for 10 min, and a precipitate formed. The
mixture was centrifuged (3750 rpm  15 min, 4 C), and the
supernatant was decanted and saved. The precipitate was
resuspended in 20 mL of 6 M GuHCl and passed through a 0.22
mm lter. Analytical HPLC and LC-MS revealed that the majority
of the precipitate was reduced 81-residue proHD6 (proHD6red,
Table S2†). The supernatant portion, which was saved from the
cleavage reaction, was dialyzed (3500 MWCO) against Milli-Q
water (2  12 h), lyophilized, and resuspended in 75 mM
HEPES, pH 8.0 containing 6 M GuHCl and 2 mM TCEP. Aer 15
min incubation at room temperature, the solution was acidied
with 6% aqueous TFA (10% v/v). Analytical HPLC and LC-MS
revealed that proHD6 in the supernatant portion was
completely reduced. Subsequently, proHD6red from both
supernatant and precipitate portions was puried by prepara-
tive HPLC using a solvent gradient of 33–38% B over 16 min at
10 mL min1. The desired product eluted at 14.2 min and was
lyophilized to afford a white powder (z0.5 mg L1 of culture,
Table S2†).Oxidative folding
Reduced proHD6 was oxidatively folded to afford a single
regioisomer with the native S–S bonds by modifying a literature
procedure.15,49 A 6 mg portion of proHD6red was dissolved in 1
mL of 8 M GuHCl containing 3 mM glutathione and 0.3 mM
glutathione disulde. Then, 3 mL of 250 mM NaHCO3 was
added to the solution to raise the pH toz8.3 and afford a nal
peptide concentration of 1.5 mg mL1. The mixture was incu-
bated at room temperature for 16 h. The resulting solution was
analyzed by HPLC and LC-MS to conrm that proHD6red was
completely converted to a single oxidized species. The solution
was centrifuged (3750 rpm  10 min, 4 C), passed through
a 0.22 mm lter, and puried by preparative HPLC using
a solvent gradient of 32–37% B over 16 min at 10 mLmin1. The
single regioisomer obtained by oxidative folding eluted at 13.1
min and was lyophilized, which afforded pure oxidized proHD6
as a white powder (z0.2 mg L1 of culture). Analytical HPLC
indicated that proHD6 was obtained in high purity (Fig. S3b†).
Thiol quantication conrmed that proHD6 had no free Cys
residues and LC-MS conrmed its identity (Table S2†).This journal is © The Royal Society of Chemistry 2016
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View Article OnlineAntimicrobial activity assays
The assays were performed according to a literature proce-
dure.15 Briey, a 90 mL aliquot of the diluted bacterial culture
was added to each well and then to each well was added 10 mL of
a 10 concentrated aqueous peptide solution (500 mM) or sterile
Milli-Q water as a no-peptide control. The plate was incubated
for 1 h (37 C, 150 rpm). The serial dilution for CFU counting
was conducted as previously reported.15 These assays were
performed with at least two independently prepared and puri-
ed samples of each peptide and in three independent trials.
The resulting averages and standard deviations are reported.Trypsin-catalyzed cleavage of proHD6
A solution of proHD6 (100 mM, 180 mL) was prepared in 100 mM
Tris–HCl, 20 mM CaCl2, pH 8.0. A 1 mg mL
1 stock solution of
TPCK-treated trypsin (Worthington) in Milli-Q water was added
to the solutions to achieve a nal concentration of 0.01 mg
mL1. The mixture was incubated at room temperature with
gentle shaking. A 24 mL aliquot was taken at varying time points,
diluted with 56 mL of Milli-Q water, and quenched with 8 mL
of 6% aqueous TFA. The resulting samples were vortexed,
centrifuged (13 000 rpm  10 min, 4 C), and analyzed by HPLC
(10–60% B over 30 min at 1 mL min1).Negative-staining transmission electron microscopy
The samples for TEM were prepared by following a literature
protocol.15 For each sample, a 5 mL aliquot of peptide solution
(20 mM in 10 mM sodium phosphate pH 7.4 or 10 mM Tris-
maleate pH 6.4) was placed onto the carbon-coated surface of
a copper grid (400 square mesh, Electron Microscopy Sciences).
Aer 1 min, the grid was washed with a 5 mL aliquot of Milli-Q
water, stained with a 5 mL aliquot of 2% uranyl acetate (UA,
Electron Microscopy Sciences) in Milli-Q water three times, and
air-dried for at least 15 min before imaging. A FEI Technai Spirit
Transmission Electron Microscope was employed for all TEM
imaging (W.M. Keck Microscopy Facility, Whitehead Institute,
Cambridge, MA). TEM images were obtained with at least two
independently prepared peptides and representative images are
presented.Scanning electron microscopy
Bacteria were grown aerobically at 37 C overnight in LB media.
The next morning the strains were subcultured and grown to
mid-logarithmic phase in LB media. An aliquot of the bacteria
(0.5–2  107 CFU mL1) was removed, sedimented by centri-
fugation (7000g  2 min, 4 C), washed twice with 50 mM Tris-
maleate buffer, pH 6.4, and then resuspended in 0.5 mL of the
50 mM Tris-maleate buffer. The bacterial suspension was
incubated at room temperature for 30 min with buffer control,
0.4 mM APMSF-inactivated trypsin, 3 mM proHD6, 3 mM trypsin-
cleaved proHD6, or 3 mM HD6. Trypsin-cleaved proHD6 was
prepared by incubating 30 mM proHD6 with 4 mM trypsin
(Affimetrix, Santa Clara, CA) for 1 h at room temperature in 50
mM Tris-maleate buffer, pH 6.4. At the end of incubation, the
trypsin was inactivated by addition of APMSF (p-This journal is © The Royal Society of Chemistry 2016amidinophenylmethylsulfonyluoride HCl, Millipore, 25 mg
mL1), and the mixture was added to the bacterial suspension.
The APMSF-inactivated trypsin was similarly prepared, except
that proHD6 was omitted from the preincubation. Aer a 30
min incubation, the treated bacterial suspensions were sedi-
mented by centrifugation (7000g  5 min, 4 C), and the buffer
supernatant was carefully removed. The bacterial pellet was
then resuspended in 100 mL of Karnosky xative (2% para-
formaldehyde, 2.5% glutaraldehyde in 0.06 M Sorensen's
phosphate buffer (0.2 M sodium phosphate, pH 7.2)). Scanning
electron microscopy was performed as previously described.17
Bacterial agglutination assays
Stock solutions (50 mL) of HD6 and proHD6 (0, 50, 100, and 200
mM; 10 concentrations) were prepared in sterile Milli-Q water.
If trypsin was required, aliquots of a 1 mg mL1 stock solution
of TPCK-treated trypsin (Worthington) prepared in sterile Milli-
Q water were added to solutions of proHD6 to afford a nal
trypsin concentration of 0.01 mg mL1. The assays were then
conducted following the reported procedure.15 All assays were
conducted with at least two independently prepared and puri-
ed samples of each peptide and in three independent trials.
The resulting averages with standard deviations are reported.
Listeria invasion assays
Concentrated (20, 10 mL) solutions of HD6 and proHD6 were
prepared in sterile Milli-Q water (0, 50, 100, and 200 mM). For
conditions that required trypsin, a 1 mg mL1 stock solution of
TPCK-treated trypsin (Worthington) in sterile Milli-Q water was
added to the 20 proHD6 solutions to yield a nal trypsin
concentration of 0.01 mg mL1. A 190 mL aliquot of the diluted
bacterial culture was added to each 10 peptide solution and
the resulting mixtures were incubated at room temperature for
30 min. The invasion assays were then performed by following
a literature protocol.15,50 All invasion assays were conducted
with at least two independently prepared and puried samples
of each peptide and in three independent trials and the
resulting averages with standard deviations are reported.
Nuclear morphology assays
Nuclear morphology assays were conducted to monitor T84 cell
viability qualitatively following 1.5 h incubation with HD6 or
proHD6 following a literature protocol with modication.51 T84
cells were passed and 500 mL of cells at the density of 2  105
cells per mL was added to each well of a 24-well plate, which
contained 12 mm untreated glass coverslips 12–16 h before the
assays. The 20 mMpeptide solutions in 1 : 1 DMEM/F12 (200 mL)
were added to the cells and the cells were incubated for 1.5 h at
37 C, 5% CO2. Then, the medium was removed and the cells
were washed (1  500 mL) with PBS and xed for 5 min with 500
mL of PBS containing 4% paraformaldehyde and 4% sucrose.
The cells were subsequently washed with PBS (2  500 mL) and
bathed in 500 mL of PBS containing 800 nM Hoechst 33258
(Sigma Aldrich) for 5 min. The Hoechst solution was then
removed. The cells were washed with 500 mL of PBS, bathed in
PBS, and mounted onto glass slides using the VectashieldChem. Sci., 2016, 7, 1738–1752 | 1749
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View Article Onlineantifading reagent (Vector Labs). The samples were examined
using Zeiss LSM 710 NLO laser scanning confocal microscope
(W.M. Keck Microscopy Facility, Whitehead Institute, Cam-
bridge, MA) and 60–70 cells were scored for each sample. The
images were processed using ImageJ.Sedimentation velocity experiments
The experiments were set up as previously reported.15 In one set
of experiments, 10 concentrated proHD6 solutions in Milli-Q
water (z40 mL) were transferred to microcentrifuge tubes and
lyophilized to dryness. A 400 mL aliquot of 10 mM sodium
phosphate buffer adjusted to pH 7.4 (pre-ltered, 0.22 mm lter)
was added to each microcentrifuge tube to achieve the desired
concentrations (30, 50, 100, and 140 mM), and transferred to
AUC sample cells. The pH of each solution was measured to
conrm that it remained unchanged. The samples were
centrifuged at 42 000 rpm and 20 C until sedimentation was
complete. The absorption wavelength for optical detection was
280 nm. All SV experiments were conducted with at least two
independently prepared and puried samples of each peptide
and in at least two independent trials.
Additional SV experiments were conducted to evaluate the
effect of buffer components on the sedimentation of proHD6. In
all cases, the proHD6 samples (400 mL) were prepared as
described above except that proHD6 was dissolved in 10 mM
Tris–HCl or HEPES pH 7.4 to obtain a nal peptide concentra-
tion of 50 mM.
The details of data analysis are reported elsewhere.52
SEDNTERP53 was employed to calculate the buffer viscosity (h),
buffer density (r), and the partial specic volume (value of
proHD6 at 20 C). The theoretical sedimentation coefficients of
the proHD6 monomer and dimer were calculated by employing
eqn (1)
ssphere ¼ 0:012M
2=3ð1 vrÞ
v1=3
(1)
where ssphere is the sedimentation coefficient for an ideal sphere
in S units, M is the molar mass of the molecule of interest in
Daltons, is in milliliters per gram, and r is in grams per milli-
liter. These calculations assume that proHD6 behaves as
a smooth, compact, and spherical peptide in water at 20 C.30
The experimental sedimentation coefficients were calculated
by tting the time derivative of the sedimentation velocity
(dc/dt) data using DCDT+.29,54 The dc/dt distribution was
generated from 22 to 28 scans with a peak broadening limit of
40 kDa by using DCDT+. The results are reported in Table S4.†Sedimentation equilibrium experiments
Sedimentation equilibrium (SE) experiments were performed to
determine the molecular weight of proHD6. The proHD6
samples were prepared as described in the SV experiments with
modication. In a typical set of experiments, proHD6 solutions
in Milli-Q water (z100 mL) prepared in microcentrifuge tubes
were lyophilized to dryness. An aliquot (110 mL, pre-ltered, 0.22
mm lter) of 10mM sodium phosphate buffer adjusted to pH 7.4
was added to each tube to afford solutions with varying1750 | Chem. Sci., 2016, 7, 1738–1752concentrations of proHD6 (30, 60, and 120 mM) and transferred
to AUC sample cells. The pH of each solution was measured to
conrm that each solution remained at pH 7.4. Based on the
sedimentation coefficients obtained from the SV experiments,
equilibrium proles were obtained at rotor speeds of 30 000,
36 000, and 42 000 rpm. Once equilibrium was established, two
scans with ve replicates were recorded. The absorption wave-
length for optical detection was 280 nm, and the instrument
was maintained at 20 C.
The details of the experimental setup and data analysis are
reported elsewhere.52 SEDNTERP53 was employed to calculate
the buffer viscosity (h), buffer density (r), and the partial
specic volume (value of proHD6 at 20 C) as described in the
SV section. The molecular weight of proHD6 was determined
by global tting of the multispeed equilibrium data across
all loading concentrations at pH 7.4 using SEDPHAT.31
The Species Analysis model with mass conservation was
employed for data analysis. The bottom of the sample sector
was assigned as a oating parameter. To further evaluate
whether each least-squares curve-tting procedure converged
to a global minimum, the alternate methods of Simplex,
Marquardt–Levenberg, and simulated annealing were
employed to assess any change in the global reduced chi-
squared value.Circular dichroism spectroscopy
Peptide solutions (20 mM, 300 mL) were prepared in 10 mM
sodium phosphate buffer, pH 7.4 and transferred to a 1 mm
path-length quartz CD cell (Hellma) for all measurements. The
CD spectra were collected from 260–190 nm at 1 nm intervals (5
s averaging time, three independent scans per wavelength). The
data obtained from the three scans were averaged and the
resulting averaged spectra are reported.Thiol quantication assays
The assays were performed according to a literature proce-
dure.14,15 Briey, the peptide stock solutions were freshly
prepared in Milli-Q water (for oxidized peptides) or 0.01 M HCl
(for reduced peptides). The concentration of each stock solution
was veried using the calculated extinction coefficients (Table
S2†). The samples were prepared by diluting an aliquot of each
peptide stock solution with Ar-purged assay buffer and adding
a 42 mL aliquot of 2,20-dithiodipyridine (DTDP) as previously
described.15 The nal peptide concentrations were 2–5 mM or
6–7 mM for the reduced proHD6 and oxidized HD6/proHD6,
respectively. The resulting solutions were incubated at room
temperature for at least 15 min and the absorbance at 341 nm
was recorded. The number of free thiol residues in each peptide
sample was determined by using a reduced glutathione (GSH)
standard curve. These assays were conducted with at least two
independently prepared and puried samples of each peptide
and in three independent trials. The resulting averages (SDM)
are reported.This journal is © The Royal Society of Chemistry 2016
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